Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 11 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Ani Pharmaceuticals Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 181
- −4 vs. Q3 2023
- Shares held
- 13.6M
- +423.0K (+3.2%) vs. Q3 2023
- Total value
- $750.8M
- −$15.2M (−2.0%) vs. Q3 2023
- New holders
- 31
- 55 more added
- Sold out
- 35
- 53 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 307 | $1.90B |
| Q1 2026 | 281 | $1.80B |
| Q4 2025 | 285 | $1.67B |
| Q3 2025 | 269 | $1.87B |
| Q2 2025 | 233 | $1.29B |
| Q1 2025 | 231 | $1.34B |
| Q4 2024 | 206 | $1.07B |
| Q3 2024 | 208 | $1.12B |
| Q2 2024 | 201 | $962.3M |
| Q1 2024 | 200 | $975.2M |
| Q4 2023 | 181 | $750.8M |
| Q3 2023 | 186 | $766.4M |
| Q2 2023 | 172 | $662.5M |
| Q1 2023 | 138 | $411.7M |
| Q4 2022 | 126 | $412.4M |
| Q3 2022 | 126 | $330.3M |
| Q2 2022 | 120 | $293.4M |
| Q1 2022 | 126 | $258.8M |
| Q4 2021 | 132 | $413.4M |
| Q3 2021 | 118 | $238.8M |
| Q2 2021 | 116 | $252.7M |
| Q1 2021 | 106 | $263.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cullen Capital Management LLC | 0 | $0 | 0.00% | −6,113−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −4,581−100.0% | Sold out |
| Caxton Associates LP | 0 | $0 | 0.00% | −3,990−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −3,706−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,287−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −901−100.0% | Sold out |
| BluePath Capital Management, LLC | 0 | $0 | 0.00% | −594−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −481−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| Fisher Asset Management, LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| USA Financial Portformulas Corp | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| TSFG, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Financial Synergies Wealth Advisors, Inc. | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| BTC Capital Management, Inc. | – | – | – | – | Not filed |